IDYA
Price
$14.71
Change
-$0.86 (-5.52%)
Updated
Apr 4 closing price
Capitalization
1.29B
37 days until earnings call
SLN
Price
$2.61
Change
-$0.13 (-4.74%)
Updated
Apr 4 closing price
Capitalization
120.42M
Ad is loading...

IDYA vs SLN

Header iconIDYA vs SLN Comparison
Open Charts IDYA vs SLNBanner chart's image
IDEAYA Biosciences
Price$14.71
Change-$0.86 (-5.52%)
Volume$2.3M
Capitalization1.29B
Silence Therapeutics
Price$2.61
Change-$0.13 (-4.74%)
Volume$239.38K
Capitalization120.42M
IDYA vs SLN Comparison Chart
Loading...
IDYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IDYA vs. SLN commentary
Apr 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IDYA is a Hold and SLN is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 06, 2025
Stock price -- (IDYA: $14.71 vs. SLN: $2.61)
Brand notoriety: IDYA and SLN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IDYA: 225% vs. SLN: 90%
Market capitalization -- IDYA: $1.29B vs. SLN: $120.42M
IDYA [@Biotechnology] is valued at $1.29B. SLN’s [@Biotechnology] market capitalization is $120.42M. The market cap for tickers in the [@Biotechnology] industry ranges from $283.79B to $0. The average market capitalization across the [@Biotechnology] industry is $2.07B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IDYA’s FA Score shows that 0 FA rating(s) are green whileSLN’s FA Score has 1 green FA rating(s).

  • IDYA’s FA Score: 0 green, 5 red.
  • SLN’s FA Score: 1 green, 4 red.
According to our system of comparison, IDYA is a better buy in the long-term than SLN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IDYA’s TA Score shows that 4 TA indicator(s) are bullish while SLN’s TA Score has 4 bullish TA indicator(s).

  • IDYA’s TA Score: 4 bullish, 4 bearish.
  • SLN’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both IDYA and SLN are a good buy in the short-term.

Price Growth

IDYA (@Biotechnology) experienced а -13.72% price change this week, while SLN (@Biotechnology) price change was -24.13% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -11.00%. For the same industry, the average monthly price growth was -16.69%, and the average quarterly price growth was -18.23%.

Reported Earning Dates

IDYA is expected to report earnings on Aug 12, 2025.

SLN is expected to report earnings on May 14, 2024.

Industries' Descriptions

@Biotechnology (-11.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IDYA($1.29B) has a higher market cap than SLN($120M). IDYA YTD gains are higher at: -42.763 vs. SLN (-62.064). SLN has higher annual earnings (EBITDA): -48.99M vs. IDYA (-323.14M). IDYA has more cash in the bank: 676M vs. SLN (147M). SLN has less debt than IDYA: SLN (117K) vs IDYA (19.2M). SLN has higher revenues than IDYA: SLN (43.3M) vs IDYA (7M).
IDYASLNIDYA / SLN
Capitalization1.29B120M1,073%
EBITDA-323.14M-48.99M660%
Gain YTD-42.763-62.06469%
P/E RatioN/AN/A-
Revenue7M43.3M16%
Total Cash676M147M460%
Total Debt19.2M117K16,410%
FUNDAMENTALS RATINGS
IDYA: Fundamental Ratings
IDYA
OUTLOOK RATING
1..100
56
VALUATION
overvalued / fair valued / undervalued
1..100
58
Fair valued
PROFIT vs RISK RATING
1..100
69
SMR RATING
1..100
49
PRICE GROWTH RATING
1..100
93
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
2

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IDYASLN
RSI
ODDS (%)
Bullish Trend 3 days ago
88%
Bullish Trend 3 days ago
82%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
81%
Momentum
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 3 days ago
85%
MACD
ODDS (%)
Bearish Trend 3 days ago
73%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
79%
Bearish Trend 3 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
85%
Advances
ODDS (%)
Bullish Trend 25 days ago
77%
Bullish Trend about 1 month ago
90%
Declines
ODDS (%)
Bearish Trend 3 days ago
76%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
71%
Bullish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 3 days ago
80%
View a ticker or compare two or three
Ad is loading...
IDYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BMSTX12.27-0.73
-5.62%
MFS Blended Research Mid Cap Eq R3
MIVIX26.10-1.58
-5.71%
Madison Large Cap I
HMDYX28.54-1.75
-5.78%
Hartford MidCap Y
GMCFX25.03-1.75
-6.53%
GMO International Equity IV
ULPSX72.71-9.85
-11.93%
ProFunds UltraBull Svc

IDYA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IDYA has been loosely correlated with GRI. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if IDYA jumps, then GRI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IDYA
1D Price
Change %
IDYA100%
-5.52%
GRI - IDYA
54%
Loosely correlated
+4.86%
KRYS - IDYA
52%
Loosely correlated
-3.83%
RCKT - IDYA
51%
Loosely correlated
-7.91%
IMNM - IDYA
51%
Loosely correlated
-4.97%
DNLI - IDYA
50%
Loosely correlated
-7.90%
More